These observations may form an explanation of the lack of correlation between the IFNAR-1 and/or IFNAR-2c receptors and the maximal inhibitory effect of IFN-β, as we found in our study, but also for the much higher potency of the anti-tumour effects of IFN-β, compared with IFN-α. The gene discussed is IFNA2; the disease is neoplasm.